4//SEC Filing
ALTA BIOPHARMA PARTNERS II LP 4
Accession 0001209191-04-042016
CIK 0001034842other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:18 PM ET
Size
20.1 KB
Accession
0001209191-04-042016
Insider Transaction Report
Form 4
ALTA BIOPHARMA MANAGEMENT II LLC
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−352,434$7,440,234→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−8,049$169,922→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−403,892$8,526,564→ 807,784 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−14,858$313,652→ 29,715 total(indirect: See footnote)
MARDUEL ALIX
Other
Transactions
- Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−14,858$313,652→ 29,715 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−403,892$8,526,564→ 807,784 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−352,434$7,440,234→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−8,049$169,922→ 0 total(indirect: See footnote)
ALTA PARTNERS II INC
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−8,049$169,922→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−352,434$7,440,234→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−14,858$313,652→ 29,715 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−403,892$8,526,564→ 807,784 total(indirect: See footnote)
Transactions
- Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−8,049$169,922→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−14,858$313,652→ 29,715 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−352,434$7,440,234→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−403,892$8,526,564→ 807,784 total(indirect: See footnote)
CHAMPSI FARAH
Other
Transactions
- Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−8,049$169,922→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−403,892$8,526,564→ 807,784 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−14,858$313,652→ 29,715 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−352,434$7,440,234→ 0 total(indirect: See footnote)
ALTA BIOPHARMA PARTNERS II LP
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−403,892$8,526,564→ 807,784 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−14,858$313,652→ 29,715 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−352,434$7,440,234→ 0 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2004-08-20$21.11/sh−8,049$169,922→ 0 total(indirect: See footnote)
Footnotes (4)
- [F1]Alta California Partners, L.P. ("ACP") distributed its shares to its general & limited partners on 8/20/04. Jean Deleage, Director, is a General Partner ("GP") of Alta California Mgmt. Partners, L.P. ("ACMP")(which is the GP of ACP) & a managing member of Alta Embarcadero Partners, LLC ("AEP"). Alta Partners ("AP") provides investment advisory services to several venture capital funds including ACP & AEP. The respective GP and members of ACP & AEP exercise sole voting & investment powers with respect to the shares owned by the funds. Jean Deleage,Garrett Gruener & Guy Nohra are general partners of ACMP, and Jean eleage & Garrett Gruener are members of AEP (collectively known as the "principals"). As GP & members, they may be deemed to share voting & investment powers over the shares owned by the foregoing funds. The principals disclaim beneficial ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein.
- [F2]Alta Embarcadero Partners, LLC distributed it shares of Common Stock to its members on 8/20/04. See footnote for Alta California Partners, L.P. on this Form 4.
- [F3]Alta BioPharma Partners II, L.P. ("ABPII") distributed 403,892 shares to its general and limited partners on 8/20/04. Jean Deleage, Director, is a managing director of Alta BioPharma Mgmt.II, LLC (which is the General Partner ("GP") of ABPII) & a manager of Alta Embarcadero BioPharma Partners II, LLC ("AEBPII"). Alta Partners II, Inc. ("APII") provides investment advisory services to several venture capital funds including ABPII & AEBPII. The respective GP and managers exercise sole voting & investment powers over the shares held by the foregoing funds. Jean Deleage, Alix Marduel & Farah Champsi (collectively known as the "principals") are managing directors ("md") of ABPII & managers of AEBPII. As md & managers, they may be deemed to share voting & investment powers over the shares held by the funds. The principals disclaim beneficial ownership of all such share held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein.
- [F4]Alta Embarcadero BioPharma Partners II, LLC distributed 14,858 shares to its members. See footnote for Alta BioPharma Partners II, L.P. on this Form 4.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001163156
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:18 PM ET
- Size
- 20.1 KB